{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:12:07Z","timestamp":1780431127144,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.jpba.2013.01.032","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T01:02:37Z","timestamp":1359594157000},"page":"65-74","source":"Crossref","is-referenced-by-count":105,"special_numbering":"C","title":["Using an innovative Quality-by-Design approach for development of a stability indicating UHPLC method for ebastine in the API and pharmaceutical formulations"],"prefix":"10.1016","volume":"78-79","author":[{"given":"Alexander H.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2013.01.032_bib0005","series-title":"Erg\u00e4nzungslieferung","author":"Kommentar zum Europ\u00e4ischen Arzneibuch","year":"2005"},{"key":"10.1016\/j.jpba.2013.01.032_bib0010","series-title":"Monograph Ebastine in the European Pharmacopoeia","year":"2011"},{"key":"10.1016\/j.jpba.2013.01.032_bib0015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4103\/0250-474X.43022","article-title":"Determination of ebastine in pharmaceutical formulations by HPLC","volume":"70","author":"Prabu","year":"2008","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2013.01.032_bib0020","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/chromsci\/bms082","article-title":"Gradient HPLC-DAD determination of two pharmaceutical mixtures containing the antihistaminic drug ebastine","volume":"50","author":"Haggag","year":"2012","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jpba.2013.01.032_bib0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1752-153X-5-24","article-title":"Validated stability indicating liquid chromatographic determination of ebastine in pharmaceuticals after pre column derivatization: application to tablets and content uniformity testing","volume":"5","author":"Ibrahim","year":"2011","journal-title":"Chem. Cent. J."},{"issue":"Suppl (2)","key":"10.1016\/j.jpba.2013.01.032_bib0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1365\/s10337-009-0992-4","article-title":"Development and validation of a stability-indicating LC method for determination of Ebastine in tablet and syrup","volume":"69","author":"Arend","year":"2009","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2013.01.032_bib0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jchromb.2004.09.017","article-title":"Simultaneous determination of ebastine and its three metabolites in plasma using liquid chromatography-tandem mass spectrometry","volume":"813","author":"Kang","year":"2004","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2013.01.032_bib0040","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1365\/s10337-009-1328-0","article-title":"Simultaneous determination of ebastine and its active metabolite (carebastine) in human plasma using LC\u2013MS\u2013MS","volume":"70","author":"Feng","year":"2009","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2013.01.032_bib0045","series-title":"Sample Preparation of Pharmaceutical Dosage Forms","year":"2011"},{"key":"10.1016\/j.jpba.2013.01.032_bib0050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/biomet\/33.4.305","article-title":"The design of optimum multifactorial experiments","volume":"33","author":"Plackett","year":"1946","journal-title":"Biometrika"},{"key":"10.1016\/j.jpba.2013.01.032_bib0055","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/chromsci\/43.10.505","article-title":"Improvement of the chromatographic separation of several 1,4-dihydropyridines calcium channel antagonist dugs by experimental design","volume":"43","author":"Baranda","year":"2005","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jpba.2013.01.032_bib0060","first-page":"10","article-title":"Optimization of analytical methods using factorial designs","volume":"4","author":"Wan Raihana","year":"2012","journal-title":"Sep. Sci."},{"key":"10.1016\/j.jpba.2013.01.032_bib0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/chrsci\/49.6.439","article-title":"Quality by design (QbD) based development of a stability indicating HPLC method for drug and impurities","volume":"49","author":"Karmarkar","year":"2011","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jpba.2013.01.032_bib0070","doi-asserted-by":"crossref","first-page":"755","DOI":"10.4155\/bio.12.47","article-title":"New methodology for the development of chromatographic methods with bioanalytical application","volume":"4","author":"Rozet","year":"2012","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2013.01.032_bib0075","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1016\/j.chroma.2010.02.001","article-title":"Aspects of the design space in high pressure liquid chromatography method development","volume":"1217","author":"Moln\u00e1r","year":"2010","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2013.01.032_sbref0080a","series-title":"Computer-Assisted Method Development for High Performance Liquid Chromatography","author":"Snyder","year":"1990"},{"key":"10.1016\/j.jpba.2013.01.032_sbref0080b","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9673(01)89128-7","volume":"485","year":"1989","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2013.01.032_bib0085","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0021-9673(00)00851-7","article-title":"Selectivity differences for C18 and C8 reversed-phase columns as a function of temperature and gradient steepness, I. Optimizing selectivity and resolution","volume":"897","author":"Dolan","year":"2000","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2013.01.032_bib0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0021-9673(00)00855-4","article-title":"Selectivity differences for C18 and C8 reversed-phase columns as a function of temperature and gradient steepness, II. Minimizing column reproducibility problems","volume":"897","author":"Dolan","year":"2000","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2013.01.032_bib0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0021-9673(02)00731-8","article-title":"Computerized design of separation strategies by reversed-phase liquid chromatography: development of DryLab software","volume":"965","author":"Molnar","year":"2002","journal-title":"J. Chromatogr. A"},{"issue":"Suppl (1)","key":"10.1016\/j.jpba.2013.01.032_bib0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10337-011-1968-8","article-title":"From Csaba Horv\u00e1th to quality by design: visualizing design space in selectivity exploration of HPLC separations","volume":"73","author":"Moln\u00e1r","year":"2011","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2013.01.032_bib0105","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.aca.2011.04.010","article-title":"A stepwise strategy employing automated screening and DryLab modeling for the development of robust methods for challenging high performance liquid chromatography separations: A case study","volume":"696","author":"Jayaraman","year":"2011","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2013.01.032_bib0110","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.chroma.2011.12.041","article-title":"Quality by design: multidimensional exploration of the design space in high performance liquid chromatography method development for better robustness before validation","volume":"1232","author":"Monks","year":"2012","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2013.01.032_bib0115","series-title":"Practical HPLC Method Development","author":"Snyder","year":"1997"},{"key":"10.1016\/j.jpba.2013.01.032_bib0120","unstructured":"FDA's Pharmaceutical Current Good Manufacturing Practices (cGMPs) for the 21st Century\u2014A risk-based approach. http:\/\/www.fda.gov\/downloads\/Drugs\/DevelopmentApprovalProcess\/Manufacturing\/QuestionsandAnswersonCurrentGoodManufacturingPracticescGMPforDrugs\/UCM176374.pdf."},{"key":"10.1016\/j.jpba.2013.01.032_bib0125","unstructured":"ICHQ8 (R2) International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q8 (R2): Pharmaceutical development (2009). http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q8_R1\/Step4\/Q8_R2_Guideline.pdf."},{"key":"10.1016\/j.jpba.2013.01.032_bib0130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0021-9673(02)00066-3","article-title":"Computer-assisted optimization in the development of a high-performance liquid chromatographic method for the analysis of kava pyrones in Piper methysticum preparations","volume":"948","author":"Schmidt","year":"2002","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2013.01.032_bib0135","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1081\/JLC-200051475","article-title":"Development of an HPLC method for the determination of hydroxycinnamic acid derivates in Cimicifuga racemosa (black cohosh) extracts using an automated method development system","volume":"28","author":"Schmidt","year":"2005","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jpba.2013.01.032_bib0140","unstructured":"Course Manuscript Quality by Design Principles for the Development of Analytical HPLC Methods organized by Moln\u00e1r-Institute, Berlin, Germany, November 2011."},{"key":"10.1016\/j.jpba.2013.01.032_bib0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.chroma.2006.06.006","article-title":"Selectivity in reversed-phase separations \u2013 influence of the stationary phase","volume":"1127","author":"Neue","year":"2006","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2013.01.032_bib0150","first-page":"13","article-title":"3-dimensional retention modelling of gradient time, ternary solvent-strength and temperature of the reversed-phase gradient liquid chromatography of a complex mixture of 22 basic and neutral analytes using DryLab\u00ae 2010","volume":"3","author":"Euerby","year":"2010","journal-title":"Chromatogr. Today"},{"key":"10.1016\/j.jpba.2013.01.032_bib0155","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jpba.2011.04.015","article-title":"Expanding the term Design Space in high performance liquid chromatography (I)","volume":"56","author":"Monks","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2013.01.032_bib0160","unstructured":"ICHQ2 (R1) International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q2 (R1): Validation of Analytical Procedures: Text and Methodology, 2005. http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q2_R1\/Step4\/Q2_R1_Guideline.pdf."},{"key":"10.1016\/j.jpba.2013.01.032_bib0165","series-title":"Quality by Design in Pharmaceutical Analysis","author":"Course Manuscript","year":"2012"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513000496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513000496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T22:55:25Z","timestamp":1539903325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708513000496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":34,"alternative-id":["S0731708513000496"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2013.01.032","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}